Advertisement

Topics

Latest Women's Health NewsRSS

05:27 EST 19th November 2017 | BioPortfolio

Colorectal Cancer Drug Development Pipeline Review, 2017 [Report Updated: 22092017] Prices from USD $3995

Colorectal Cancer Drug Development Pipeline Review, 2017SummaryThis report provides an overview of the colorectal cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for anal, rectal and colorectal cancer, and features dormant and discontinued projects.Anal cancer starts in the anus. Symp...

Guided Therapeutics Inc GTHP Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryGuided Therapeutics Inc GTI, formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the noninvasive cervical cancer detection markets. Its products include luviva advanced cervical scan and esophageal dysplasia detection system. GTI develops technology to painlessly detect dis...

Pancreatic Cancer Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10102017] Prices from USD $4600

DelveInsight's Pancreatic Cancer Market Insights, Epidemiology and Market Forecast Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to Pancreatic Cancer Market Insights, Epidemiology and Market Forecast for the 7MM United States, Germany, France, Italy, Spain and UK for the study period undertaken from 20152025.This...

Global and Regional HPV Testing Market Research Report 2017 [Report Updated: 01011970] Prices from USD $3500

SummaryThe human papillomavirus HPV test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three subsegments, namely, followup testing, cotesting, HPV primary testing.Market Segment as follows:By Region AsiaPacific North America Europe South Amer...

TapImmune Inc TPIV Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryTapImmune Inc TapImmune is a clinicalstage immunooncology company specializing in the development of innovative peptide, genebased immunotherapeutics and vaccines for the treatment of cancer and metastatic disease. The company's pipeline products include TPIV 200, which is intended for the treatment of ovarian and breast cancers. It combines set of licensed technologies, including peptide a...

Log in to the Live Webcast Today – 1:00 PM Eastern

Watch the LIVE WEBCAST starting at 1 pm, Eastern, Saturday, November 18, 2017 in partnership with Georgetown University Hospital, GRACE presents: 2017 Advances in Immunotherapy: What Lung Cancer Patients Need to KnowRelated Posts:

Involve plastic surgeons early in breast cancer treatment

Women who lose part or all of one or both breasts due to breast cancer surgery may choose to have new breasts created with their own tissue — a process that also may or may not involve breast implants. A wide range of reconstruction procedures is available, including a variety of flaps and options to […]

Bladder cancer Epidemiology Forecast to 2025 [Report Updated: 10102017] Prices from USD $2200

DelveInsight Bladder cancer Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Bladder cancer in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Bladder cancer prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk fact...

Global Cancer Angiogenesis Inhibitor Market Research Report Forecast 2017 to 2021 [Report Updated: 30102017] Prices from USD $2800

The Global Cancer Angiogenesis Inhibitor Market Research Report Forecast 20172021 is a valuable source of insightful data for business strategists. It provides the Cancer Angiogenesis Inhibitor industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an elaborate description of the value chain and its dis...

Bile Duct Cancer Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10102017] Prices from USD $4600

DelveInsight's Bile Duct Cancer Market Insights, Epidemiology and Market Forecast Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to Bile Duct Cancer Market Insights, Epidemiology and Market Forecast for the 7MM United States, Germany, France, Italy, Spain and UK for the study period undertaken from 20152025.This r...

Global and Regional Colposcopy Market Research Report 2017 [Report Updated: 01011970] Prices from USD $3500

SummaryColposcopy is a medical diagnostic procedure to examine an illuminated, magnified view of the cervix and the tissues of the vagina and vulva. Many premalignant lesions and malignant lesions in these areas have discernible characteristics which can be detected through the examination. It is done using a colposcopy, which provides an enlarged view of the areas, allowing the colposcopies to vi...

Colorectal Cancer CRC Epidemiology Forecast to 2025 [Report Updated: 10102017] Prices from USD $2200

DelveInsight Colorectal Cancer CRC Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Colorectal Cancer CRC in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Colorectal Cancer CRC prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the...

Global and Regional Capecitabine Market Research Report 2017 [Report Updated: 08112017] Prices from USD $3500

SummaryCapecitabine is an orallyadministered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil antimetabolite in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.Market Segment as follows:By Region AsiaPacific North America Europe South America ...

Global Breast Biopsy Devices Market Research Report 20112023 [Report Updated: 08112017] Prices from USD $2030

SummaryBreast Biopsy is a procedure in which a sample of a suspicious breast growth is removed and examined, usually for the presence of cancer. The sample is suctioned out through a needle or removed surgically. A breast biopsy is the best way to evaluate if a suspicious lump or portion of your breast is cancerous.The global Breast Biopsy Devices market will reach xxx Million USD in 2017 with CAG...

Pregnant and on the Run: We Must Do Better to Protect Refugees on Their Journeys to Motherhood

by Mary-Ann Etiebet, Executive Director, Merck for Mothers SOURCE: Merck & Co., Inc. DESCRIPTION:I keep thinking about Nour from Syria, who at age 22 discovered she was pregnant with her first child while running for her life. I think of how Nour spent her pregnancy: uncertain, undernourished, waiting things out in a cold tent at a refugee camp in Greece. I imagine her experiencing the pains ...

Siddhartha Mukherjee: Gene research critical in fight against cancer

SLE linked with increased atherosclerotic risk in early disease stages

According to findings, systemic lupus erythematosus appears to increase atherosclerotic risk in its early phase, while traditional risk factors have a greater impact on atherosclerosis during the later stages of SLE.In the study, researchers evaluated 210 women with SLE and 138 healthy controls who were enrolled in the Toronto Risk Factor Study. The Toronto Risk Factor Study began in 1998 and enro...

FDA Creates Pathway to Review Tumor Assays Based on Approval of MSK Panel

Memorial Sloan Kettering Cancer Center (MSK) has won the FDA’s first authorization for a first tumor-profiling laboratory-developed test (LDT)—an approval that has led the agency to create a regulatory pathway for reviewing similar assays. MSK-IMPACT (Integrated Mutation Profiling of Actionable Cancer Targets) is a 468-gene panel intended to detect gene mutations and other critical geneti...

FDA Creates Pathway to Reviewing Tumor Assays Based on Approval of MSK Panel

Memorial Sloan Kettering Cancer Center (MSK) has won FDA authorization for its MSK-IMPACT (Integrated Mutation Profiling of Actionable Cancer Targets) multiplex oncopanel—the first tumor-profiling laboratory-developed test (LDT) to win agency approval. MSK-IMPACT is a 468-gene panel intended to detect gene mutations and other critical genetic aberrations in both rare and common cancers. Sin...

Adalimumab and trastuzumab biosimilars approved in South Korea

South Korean biosimilars maker Samsung Bioepis announced on 9 November 2017 that it had received marketing approval for its biosimilar version of Roche’s blockbuster breast cancer therapy Herceptin (trastuzumab) from Korea’s Ministry of Food and Drug Safety (MFDS). The news follows another announcement by the company on 22 September 2017 that it had also gained approval for its adalimumab bios...

Opportunities and challenges for biosimilars in oncology

The rapid increase in healthcare costs, particularly for cancer drugs, has had a major impact on providers, practices, payers and patients, according to Dr Gary Lyman of the Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA, USA [1, 2].

Global and Regional Colposcope Market Research Report 2017 [Report Updated: 09112017] Prices from USD $3500

SummaryColposcope is a medical diagnostic procedure to examine an illuminated, magnified view of the cervix and the tissues of the vagina and vulva. Many premalignant lesions and malignant lesions in these areas have discernible characteristics which can be detected through the examination. It is done using a Colposcope, which provides an enlarged view of the areas, allowing the colposcopies to vi...

Discontinuation of postmenopausal hormone therapy elevates cardiac, stroke death risk

In the first year after discontinuation of postmenopausal hormone therapy, the risk for cardiac and stroke death increases, particularly among women aged younger than 60 years, according to findings published in Menopause.“Associations between the long-term use of postmenopausal hormone therapy and risks of cardiovascular diseases have been studied for decades. The data are not uniform, perhaps ...

Study finds sleep disturbance common among women with diabetes

Michael JohnsenThe findings suggest that clinicians should pay extra attention to females when conducting sleep-related assessments. read more

Ascensia Diabetes Care celebrates 30 women as part of World Diabetes Day recognition

Michael JohnsenThe portraits of women from around the world have been individually painted by hand on tablet devices. They will be published online and via social media to engage members of the public. read more

Quick Search
Advertisement
 

review and buy Women's Health market research data and corporate reports here